Strategic relations
Create and steward international relationships that support the Group's ambitions, market access and institutional standing.
Institutional engagement · Commercial alliances · Specialist networks
Start a conversation Pharmaceutical market access & international execution — Mauritius
Regulated pharmaceutical markets. International execution.
The Green Merchant helps pharmaceutical manufacturers and distributors enter and grow in highly regulated international markets through market strategy, regulatory coordination and end-to-end commercial execution.
Explore our pharmaceutical capability01 / About
The Group's international pharmaceutical platform
Market access, regulatory insight and commercial execution.
The Green Merchant is the international pharmaceutical market-access and strategic-relations arm of The Cilo Cybin Group. We connect qualified manufacturers with licensed importers and distributors, then help coordinate the work required to turn an opportunity into lawful, sustainable trade.
Investment and international asset ownership support this operating focus. They enable the Group to hold selected intellectual property, technology, brands and commercial interests that strengthen pharmaceutical capability and long-term market participation.
Core capabilityPharmaceutical market access
Building manufacturer, distributor and specialist networks for regulated market entry and repeat trade.
Commercial capabilityInternational execution
Coordinating product positioning, documentation, regulatory workstreams, supply planning and partner delivery.
Supporting capabilityInvestment and assets
Holding selected technology, brands, intellectual property and commercial interests that advance the pharmaceutical mandate.
What we do
One accountable interface from opportunity assessment to execution.
We coordinate counterparty due diligence, product and market fit, regulatory pathways, commercial structure, documentation and supply planning.MauritiusInternational base
04 / Supporting mandate
Investment and asset ownership that strengthen pharmaceutical capability.
International investment
Identify, invest in and hold selected physical and intellectual assets internationally with a patient, governed perspective.
Equity interests · Technology · Brands · Intellectual propertyInternational deal facilitation
Originate, structure and coordinate cross-border B2B opportunities while applying pharmaceutical, regulatory and market expertise throughout the relationship.
Partner origination · Product positioning · Turnkey executionSector advancement
Focus on pharmaceutical and alternative-medicine opportunities with credible science, lawful pathways and durable strategic relevance.
Research capability · Regulated pathways · International collaboration03 / Pharmaceutical focus
International by design
Pharmaceutical products, regulated pathways and credible market demand.
We prioritise opportunities with defined patient or market need, credible counterparties, a lawful regulatory pathway and a realistic route to supply.
- 01 Pharmaceutical assets
- 02 Alternative medicine
- 03 Intellectual property
- 04 Strategic market access
- 05 Institutional relationships
02 / Pharmaceutical capability
A complete international B2B interface
From market opportunity to compliant pharmaceutical supply.
The Green Merchant works between qualified pharmaceutical manufacturers, licensed importers and established distribution partners. We assess product and partner fit, shape the market proposition and coordinate the commercial, regulatory and supply workstreams required for execution.
This includes medicines that are not registered in a destination market where supply may lawfully proceed through named-patient, special-access, import-permit or other authorised pathways. Every opportunity remains subject to the applicable regulatory, quality, licensing and professional requirements of the markets involved.
Experience that adds value
Our team brings years of pharmaceutical-sector experience across multiple continents, together with a deep understanding of regulatory requirements, market dynamics, product positioning and commercial execution. Having facilitated a substantial number of international transactions, we work alongside suppliers and customers to strengthen their businesses, reduce execution risk and create the foundations for sustainable long-term growth.
Partner and portfolio fit
Identify credible counterparties and assess whether their capabilities, products, territories and long-term objectives are genuinely aligned.
Product and market positioning
Apply sector knowledge and local-market insight to help position the product, commercial proposition and route to market appropriately.
Regulatory and market strategy
Coordinate regulatory, quality, documentation and market-entry workstreams with qualified specialists and licensed operators.
Long-term commercial execution
Support the relationship beyond the transaction through supply planning, compliant logistics, counterparty coordination and continuing growth initiatives.
05 / Our approach
Selective by nature
We begin with strategic fit, not transaction volume.
We assess each opportunity against the Group's capabilities, market need, regulatory feasibility, counterparty quality and commercial durability. Opportunities that cannot meet those tests do not proceed.
Strategic relevance
We look for opportunities that can extend the Group's capability, knowledge, access or resilience—not investments that sit apart from its purpose.
Responsible structure
Ownership, intellectual property and partnerships must be clearly structured, appropriately governed and capable of standing up to institutional scrutiny.
International usefulness
We favour assets and relationships that can create value across markets, connect specialist expertise or support credible international expansion.
Long-term alignment
We seek counterparties whose objectives, standards and time horizons support durable cooperation rather than short-term promotional activity.
Decision criteriaEvidence, regulatory feasibility and commercial durability guide every decision.
06 / Leadership
Leadership accountable for international strategy and execution.
Board profiles will appear here once approved for The Green Merchant in Dave.
07 / Governance
Accountable by design
Governance built into every mandate.
International transactions, asset ownership and regulated-market activity demand clear authority, documented decisions and accountable execution. These controls form part of how we assess, structure and manage every engagement.
Clear mandates
Defined authority, ownership and decision rights for each relationship, asset and transaction.
Regulatory discipline
Market activity proceeds only through lawful pathways with the required licences, approvals and controls.
Controlled information
Approved records and reporting support consistent communication, oversight and accountability.